Media Center

Filter by year:

May 28, 2026

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

May 07, 2026

Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update

Feb 26, 2026

Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering

Jan 29, 2026

Generate:Biomedicines Welcomes Aarif Khakoo, MD, MBA, as Chief Scientific Officer

Dec 01, 2025

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

Sep 25, 2025

Generate:Biomedicines to Present Phase 1 Results for AI-Engineered GB-0895 in Asthma at the European Respiratory Society International Congress

Sep 17, 2025

Generate:Biomedicines Welcomes Laurie Lee, MD, as Chief Medical Officer for the Immunology & Inflammation Portfolio

Apr 01, 2025

Generate:Biomedicines Expands Board of Directors with Appointment of Marsha Fanucci

Jan 09, 2025

Generate:Biomedicines Provides Update on its Platform and Pipeline Powered by AI at the 43rd Annual J.P. Morgan Healthcare Conference

'